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Abstract
Background: Paracoccidioides brasiliensis and P. lutzii cause paracoccidioidomycosis (PCM). P. brasiliensis main diagnostic
antigen is glycoprotein gp43, and its peptide sequence is 81% identical with a P. lutzii ortholog here called Plp43. P. lutzii
(‘‘Pb01-like’’) apparently predominates in Midwestern/Northern Brazil, where high percentages of false-negative reactions
using P. brasiliensis antigens have recently been reported. The aim of this work was to produce recombinant Plp43 to study
its antigenic identity with gp43.
Methodology: We expressed rPlp43 as a secreted major component in Pichia pastoris and studied its reactivity in
immunoblot with PCM patients’ sera from Southwestern and Midwestern Brazil.
Principal Findings: We showed that rPlp43 is not glycosylated and bears glucanase activity. The protein did not react with
anti-gp43 monoclonal antibodies in immunoblot, suggesting absence of the corresponding gp43 epitopes. Nevertheless,
common epitope(s) might exist, considering that gp43-positive PCM sera recognized rPlp43 in immunoblot, while gp43-
negative sera (33 out of 51) from patients resident in Midwestern Brazil were also rPlp43-negative. Two genotyped P. lutzii
were from patients with gp43-negative sera, suggesting that non-reactive sera are from patients infected with this species.
Conclusion: Our data suggest that gp43 and Plp43 bear one or only a few common epitopes and that gp43 cannot be used
in diagnosis of PCM patients infected with P. lutzii probably because Plp43 is poorly expressed during infection.
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Introduction
Until recently, all fungal isolates causing paracoccidioidomyco-
sis (PCM) were considered to be from a single species named
Paracoccidioides brasiliensis. Multilocus studies including 65
clinical and environmental isolates from Latin American countries
showed that P. brasiliensis is a complex of at least three
phylogenetic species: S1 (species 1), the most numerous; PS3
(phylogenetic species 3), composed of clonal samples from
Colombia; and PS2 that is phylogenetically cryptic and groups
six isolates bearing the most polymorphic genes [1]. Later studies
including samples from Midwestern and Northern Brazil showed
that 17 isolates formed a more distant clade from S1/PS3/PS2
[2]. They have the same genetic profile as Pb01, which has been
highly used as model in the Paracoccidioides literature [3].
Independent and concatenated genealogies derived from the
concordance method of phylogenetic species recognition supported
the ‘‘Pb01-like’’ clade as a new phylogenetic species [2], recently
recognized a distinct species, named P. lutzii, based not only on
phylogeny, but also on comparative genomics [4], recombination
analysis, and morphological features [5].
P. brasiliensis and P. lutzii are temperature-dependent dimor-
phic fungi and PCM is a primary granulomatous systemic mycosis,
whose infection occurs by inhalation of fungal conidia produced
by environmental mycelia [5]. Infectious particles transform into
the pathogenic yeast form in the pulmonary alveolar epithelium,
where infection starts, but the yeasts can then spread to other body
sites. Active pulmonary or lymphatic PCM forms occur in up to
2% of infected individuals, who can reach 10 million throughout
endemic areas of Latin America [6]. Differences in clinical
manifestations related to the Paracoccidioides species are suggest-
ed, but that kind of association needs further investigation [5].
Mycological diagnosis based on the finding of fungal species
identified in clinical specimens is still gold standard for mycoses. In
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PCM caused by P. brasiliensis, serological diagnosis and follow up
are also useful and accurate tools used by clinicians [7]. This is due
to the expression of fungal glycoprotein gp43, which is a major
antigen bearing species-specific peptide epitopes [8]. The PbGP43
gene is composed of two exons encoding 416 amino acids that
include a 35-residue signal peptide [9]. The translated protein is
structurally related to beta-1,3-glucanases, however the expressed
protein in culture medium is inactive [9]. Processed extracellular
gp43 contains a single N-glycosylation site that is occupied by a
high-mannose chain bearing 13 to 14 non-phosphorylated
mannose residues and one terminal b-D-galactofuranose [10].
This sugar chain can be removed enzymatically with endoglyco-
sydase H (Endo H), generating a faster migrating band in SDS-
PAGE gels [11]. Besides other types of interaction with the
immune system [12] the molecule also contains a well-studied T-
cell epitope (P10) that elicits protective cellular immunity in
experimentally infected animals and can be used in immunother-
apy in association with standard chemotherapy [13–15]. Gp43 is
secreted as clusters through defined regions of the cell wall [16].
Surface gp43 is partially responsible for adherence of yeast cells to
components of the extracellular matrix [17], like laminin and
fibronectin, in adhesion assays with Vero cells [18].
Gp43 has been tested in numerous serological assays [7,8,12]
and spontaneous anti-gp43 idiotype antibodies that could be useful
in PCM diagnosis were also found in PCM patients [19]. The
antigen is highly specific for PCM caused by P. brasiliensis when
the immunoassays preserve its natural conformation or eliminate
sugar epitopes [8,20–22]. That is true for both native and
recombinant gp43 produced in Pichia pastoris [21], which can be
purified from culture supernatants using affinity columns coupled
with anti-gp43 monoclonal antibody [23].
The most used test for PCM diagnosis is double immunodif-
fusion (I.D.) because of its simplicity, high sensitivity, and
specificity [7]. Whole P. brasiliensis preparations, generally from
yeast-form culture supernatants, are commonly used as antigen. In
these preparations, gp43 is the antigenic component responsible
for PCM specificity and positivity above 80% [24,25]. False-
negative reactions have been attributed to intense pulmonary
infection, immune depression, and to low affinity antibodies
recognizing carbohydrate epitopes [24,26]. The PbGP43 gene is
highly polymorphic at exon 2 and the most informative in
multilocus studies [1,2,27]. As a consequence, gp43 has isoforms
varying in isoelectric point (pIs) according with the genotype group
[27, reviewed in 28]. Experimental evidence with recombinant
gp43 shows, however, that most PCM sera can recognize different
P. brasiliensis isoforms [21]. That is probably due to one common
epitope that is specifically recognized by MAb17c [29].
P. lutzii (‘‘Pb01-like’’) apparently predominates in Midwestern
Brazil [5], where high percentages of false-negative I.D. reactions
using P. brasiliensis antigens have recently been reported [30].
That suggests that gp43 is not recognized by sera from patients
living in those areas. Since gp43 peptide sequence is only 81%
identical with the closest P. lutzii ortholog, here called Plp43
(PAAG_05770 at http://www.broadinstitute.org/annotation/
genome/paracoccidioides_brasiliensis/MultiHome.html), the aim
of this work was to produce recombinant Plp43 and to study its
immunological identity with gp43. We followed this strategy
because we could not detect Plp43 in Pb01 extracts using anti-
gp43 antibodies. Therefore, we could not purify or characterize
native Plp43. Our preliminary results thus suggested that either
Plp43 was expressed in Pb01 at undetectable amounts in our
culture conditions or it showed substantial antigenic differences to
prevent recognition by anti-gp43 monoclonal and polyclonal
antibodies. By working with recombinant Plp43 produced in
Pichia pastoris we observed that the molecule is not glycosylated
and that it preserves glucanase activity. We tested the recombinant
protein with a panel of PCM sera from proved cases, besides anti-
gp43 MAbs. Our data suggest that gp43 and Plp43 bear one or
only a few common epitopes and that gp43 cannot be used in
diagnosis of PCM patients infected with P. lutzii probably because
Plp43 is poorly expressed during infection.
Materials and Methods
Sera
Anti-gp43 monoclonal antibodies have previously been ob-
tained in our laboratory [11]. PCM sera were obtained from
patients showing varied clinical forms and that were either
untreated or under treatment. Sera from Brazilian Midwest (51
samples) were from Dr. Rosane Hahn’s collection (UFMT,
Cuiaba´, Brazil). The corresponding patients were diagnosed with
PCM using mycological methods of visualizing the fungus in
clinical samples. Sera from Brazilian Southeast (50 samples) were
from Dr. Zoilo Pires de Camargo’s collection (UNIFESP, Sa˜o
Paulo, Brazil); positivity in I.D. serological tests denoted PCM.
This study was approved by the Research Ethics Committee with
protocol numbers 0366/07; 1796/10 by Universidade Federal de
Sa˜o Paulo and CAAE: 17177613.6.0000.5541 by the Federal
University of Mato Grosso (UFMT). All patient samples were
anonymized.
Synthesis of Plp43 cDNA and Expression in Bacteria and
P. pastoris
A fragment corresponding to Plp43 cDNA (1,167 kb) devoid of
84 bp from N-terminal was reverse transcribed from DNA-free
total RNA purified from P. lutzii Pb01. Total RNA extraction was
performed in the presence of TRIzol reagent (Invitrogen),
according with the manufacturer’s recommendations and our
previous report [21], from yeast cells cultivated at 36uC, with
shaking, in mYPD (0.5% yeast extract, 0.5% peptone-casein, and
1.5% glucose, pH 6.5). PlP43 cDNA was obtained by reverse
transcription-PCR (RT-PCR) using the ThermoScript RT-PCR
system (Gibco). Specific antisense primer gp01AS (59-
GGTACCTCAATCCACCATACTTCCTA-39), that has a 59
KpnI cleavage site (Fig. 1), was used to obtain the first strand. The
second strand of the open reading frame was elongated under
Author Summary
Paracoccidioides lutzii is currently recognized as a distinct
species from P. brasiliensis that until then was solely
responsible for paracoccidioidomycosis (PCM). Serological
diagnostic of this primary systemic mycosis is quite
sensitive due to the expression of P. brasiliensis antigen
gp43, which has specific peptide epitopes recognized by
patients’ sera. Unexpected PCM false-negative reactions
have recently been reported for patients from Midwestern/
Northern Brazil, where P. lutzii (‘‘Pb01-like’’) apparently
predominates. In our work, 33 PCM false-negative sera
from Midwestern Brazil, including two cases of P. lutzii
genotyped isolates, did not recognize recombinant Plp43
(gp43 ortholog from Pb01) or gp43 (native purified or
recombinant), suggesting Plp43 is possibly underex-
pressed in vivo. Gp43-positive sera reacted with rPl43
showing that common epitopes do exist, although anti-
gp43 MAbs did not recognize the orthologous P. lutzii
protein. The main finding of our work is that gp43 cannot
be used in diagnosis of PCM patients infected with P. lutzii.
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standard PCR conditions with the sense primer gp01S (59-
GTCGACAGGCAAAGTCAGCAATA-39), containing a SalI
site, which anneals immediately downstream a predicted signal
peptide.
The PCR fragment was purified after electrophoresis from
agarose gel using the QIAEXII kit (Qiagen), and then cloned into
pGEM-T Easy vector (Promega) for maintenance. The cloned
fragment was sequenced to confirm ORF identity and subcloned
into the SalI/KpnI sites of the bacterial expression vector pHIS1
[31]. The recombinant protein was expressed in Escherichia coli
BL21 pLysS genotipe F2 cytoplasm with a His6 tag to facilitate
purification in a nickel column.
To obtain recombinant Plp43 in a eukaryotic system, the insert
was excised from pHIS1 and subcloned into pPIC9 (Invitrogen)
EcoR1/Not1 sites for expression in Pichia pastoris. P. pastoris was
also transformed with pPIC9 alone (empty vector, EV) to be used
Figure 1. Amino acid sequence alignment and molecular models show differences between Plp43 (from Pb01) and gp43 (from
Pb18). Differences in amino acid residues can be seen. Known sequence features are indicated: SP (signal peptide), MAb3e epitope (D/purple), T-cell
P10 epitope (grey shade with boxed antigenic core; A/navy), N-glycosylation site (N-gly, C/green), and NEP glucanase active site (Glu, B). The
sequences corresponding to primers gp01S and gp01AS used to amplify PlP43 ORF are shown. In the molecular models below, arrows (1–4) point to
remarkable differences between Plp43 and gp43; caps letters indicate the motifs above specified. Yellow, beta-sheets; magenta, alpha-helix.
doi:10.1371/journal.pntd.0003111.g001
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as negative control. To verify P. pastoris heterologous protein
production, random individual colonies were grown for two days,
with shaking at 30uC, in BMGY (buffered minimal glycerol
complex medium), composed of 1% yeast extract, 2% peptone, 0.1
M potassium phosphate, pH 6.0, 1.34% YNB (Difco), 1%
ammonium sulfate, and 1% glycerol. Cell pellets were suspended
in one-half the initial volume of BMMY (BMGY with 1%
methanol instead of glycerol) and incubated at 30uC under
agitation for 3 days. Inducing methanol (1%) was added daily and
expression of rPlp43 was verified in stained SDS-PAGE profiles of
culture supernatants from P. pastoris clones. P. pastoris EV was
used as negative control. The best-producing clone was selected
for large-scale production of rPlp43.
Immunodiffusion (I.D.)
I.D. tests [32] were carried out only with PCM patients’ sera
from Brazilian Midwest using purified gp43 (200 ng) as antigen.
The assays were performed as described in our previous report
[21], and the results from overnight reactions were recorded after
staining precipitation bands in dried agarose with Coomasie
brilliant blue (CBB).
SDS-PAGE and Western Blotting
Protein profile analysis was obtained by SDS-PAGE and
polyacrylamide gel staining with CBB [33]. For Western blotting
reactions, the samples were transferred to nitrocellulose mem-
branes [34], which were then incubated with patients’ sera
(1:1,000) or anti-gp43 mouse monoclonal antibodies (MAb)
(10 mg/ml). Immunocomplexes were evidenced with goat anti-
human and anti-mouse, IgG-peroxidase conjugated (Sigma) and
developed by chemiluminescence with luminol (ECL reagent,
Pierce).
Enzymatic Deglycosylation
Enzymatic deglycosylation of glycoproteins was carried out with
Endo H (endo-b-N-acetylglucosaminidase, Sigma), which removes
high mannose N-linked chains, according with manufactures’
recommendations. Approximately 1 mg of protein was incubated
with reaction buffer (250 mM NaH2PO4, pH 5.5) and denaturing
solution (2% SDS and 1 M b-mercaptoethanol) at 100uC for
5 min. After cooling, 2 U of enzyme were added for overnight
incubation at 37uC. The reaction products were analyzed in
stained SDS-PAGE.
Genotyping P. lutzii Isolates
We had two paired samples of patients’ gp43-negative sera and
the corresponding fungal isolate samples. In order to genotype the
Paracoccidioides isolates to ascertain they corresponded to P. lutzii
species as hypothesized, fungal DNA was extracted [35] and used
in PCR reactions with primers that anneal to a specific region of
the HSP70 gene only present in P. lutzii (HSPMM1, 59-
AACCAACCCCCTCTGTCTTG-39, and HSPMM2, 59-TA-
CCCTGTTCGTTGGCAATG-39), as described [3]. DNA from
P. lutzii Pb01 was used as positive control and from P. brasiliensis
Pb18 as negative control.
Exoglucanase Activity
Enzymatic exoglucanase activity was performed according with
Conchie et al. [36]. Methanol-induced P. pastoris culture
supernatants were dialyzed against 50 mM acetate buffer,
pH 5.5, and incubated with PNPG substrate (p-nitrophenyl-b-
glucoside) (Sigma) at 37uC, for 4 h. The reactions were interrupted
by addition of 0.37 M Na2CO3 and color was recorded at A420.
Culture supernatants from S. cerevisiae S288, P. pastoris 339 wild
type and P. pastoris EV growing under agitation at 30uC for 24 h
were used as positive controls. BSA and native gp43 [9] were used
as negative controls.
Modeling
Tertiary protein structure model was created using Raptor X
server (http://raptorx.uchicago.edu) [37], a protein threading
program that predicts tertiary polypeptide structure based on
alignment sequence and function scores, that estimate the fitness of
a sequence-structure alignment. Protein sequences corresponding
to Pb18 gp43 and Pb01 Plp43 without signal peptide (35
aminoacids) were analyzed and main epitopes or relevant proteins
regions were highlighted.
Ethics Statement
This study was approved by the Research Ethics Committee
with protocol numbers 0366/07; 1796/10 by Universidade
Federal de Sa˜o Paulo and CAAE: 17177613.6.0000.5541 by the
Federal University of Mato Grosso (UFMT). All patient samples
were anonymized.
Results
Plp43 Sequence Features and Heterologous Expression
According to the Paracoccidioides genome data at the
Broad Institute site (http://www.broadinstitute.org/annotation/
genome/paracoccidioides_brasiliensis/MultiHome.html), the clos-
est gp43 homologous sequence from Pb01 (PAAG_05770) bears
416 amino acids translated from a 1,251-long ORF. The DNA
sequence has a predicted intron of 76 residues, while in P.
brasiliensis the gp43 intron is 78-bp long [9]. The Pb01 peptide
sequence is 81% identical to Pb18 gp43. In the alignment seen in
Figure 1, note that the signal peptide is conserved and predicted to
be 23-residue long. Nevertheless, N-terminal sequencing of
purified gp43 suggested that it expands 35 residues [9]. In that
case, the secreted proteins have a predicted molecular mass of
about 42 kDa; however the Pb01 sequence has a pI value of 9.4,
while in P. brasiliensis the calculated gp43 pI values vary between
6.8 and 8.5 [28], showing important amino acid shifts. In the
molecular model, the Plp43 N-terminus is linear, in contrast to the
gp43 beta sheet found in the same region. Number 4 denotes a
similar change, but closer to the C-terminus. In 2 and 3 there is a
spin in the secondary structure.
Figure 1 also shows that the N-glycosylation site is absent from
Pb01 Plp43, while the glucanase NEP site is preserved, thus
suggesting that the protein is not N-glycosylated and possibly
retains full enzymatic activity, as opposed to gp43 [9]. Therefore,
we called the gp43 ortholog in P. lutzii Plp43. Also note in the
molecular model that the N-glycosylation region is linear in gp43,
but forms a beta-sheet in Plp43. The P10 epitope shows enough
alterations in its core to theoretically impair Plp43 recognition by
T-cells [13]. On the other hand, the gp43 MAb3e epitope is
mostly conserved.
Previous unpublished results in our lab suggested that Plp43 was
either unexpressed in Pb01 within our in vitro conditions or
undetectable with anti-gp43 polyclonal antibodies. Therefore, due
to the consequent difficulties to work with native Plp43, we
expressed the corresponding PlP43 gene in prokaryotic and
eukaryotic systems (Figure 2) in order to study the protein
antigenic and enzymatic features.
For Plp43 heterologous expression, we used total RNA isolated
from P. lutzii Pb01 in RT-PCR reactions with specific primers
that allowed elongation of processed Plp43 lacking the first 25
Antigenic Characterization of Recombinant Plp43
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N-terminal residues and two C-terminal residues (Figure 1). The
corresponding PCR fragment was cloned into pGEM-T, se-
quenced, and subcloned into pHIS1 [31] and pPIC9 (Invitrogen)
vectors for expression in bacteria and in P. pastoris, respectively.
Expression of Plp43 in E. coli Bl21 pLysS resulted in intracellular
expression of an approximately 45-kD insoluble protein (data not
shown). The recombinant molecule was enriched in a Ni-
Sepharose 6 fast flow column under urea-denaturing conditions,
used in preliminary immunological assays and also to obtain anti-
Plp43 polyclonal rabbit serum.
Plp43 expression in P. pastoris induced for three days in
methanol resulted in a major secreted component (rPlp43) in
culture supernatants migrating at 45 kDa (Figure 2A). Due to
cloning procedures detailed in Materials and Methods, rPlp43 has
three amino acid residues translated from pHIS1 nucleotides
remaining at the 59 end.
Figure 2. Recombinant rPlp43 is not glycosylated and seems to be enzymatically active. (A) Heterologous expression of rPlp43 in P.
pastoris culture supernatants from methanol-induced recombinant yeasts containing the PlP43 insert or not (EV, empty vector). (B) SDS-PAGE profile
of rPlp43 and control gp43 before (2) and after (+) treatment with Endo H. (C) Glucanase activity against PNPG in culture supernatants from P.
pastoris expressing rPlp43 when compared with that, at equivalent total protein amount, of yeasts containing empty vector (EV), wild type P. pastoris
and S. cerevisiae. Purified gp43 was used as protein negative control at equivalent protein amount to rPlp43, as estimated in SDS-PAGE gels. BSA was
also included as negative control at higher amounts. PBS+rPlp43 (without substrate) and PNPG+enzyme buffer (without substrate) were used as
negative controls. Migration of standard molecular masses is indicated.
doi:10.1371/journal.pntd.0003111.g002
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As previously mentioned, translated Plp43 does not have any
predicted N-glycosylation site in the processed molecule, since the
NRT motif in gp43 is altered to KRT (Figure 1). We confirmed
that Plp43 is not glycosylated by treating rPlp43 with Endo H:
note in Figure 2B that both treated and untreated rPlp43 migrated
equally in SDS-PAGE, while control native gp43 (or P. pastoris
recombinant gp43r3, not shown), migrated faster due to the
cleavage of a high-mannose chain [11,21]. Migration of rPlp43
and gp43 was similar probably because rPlp43 has extra amino
acid residues resulting from cloning procedures.
We also tested if Plp43 is an active glucanase by assaying
rPlp43-containing P. pastoris culture supernatants for enzymatic
activity. Figure 2C highly suggests that rPlp43 is indeed an active
exo-glucanase, considering that an equivalent protein amount of
culture supernatant from methanol-induced P. pastoris harboring
an empty vector was 50% less active against PNPG.
Reactivity of Recombinant rPlp43 with Anti-MAbs
We tested both HisPlp43 (not shown) and rPlp43 for reactivity
with anti-gp43 MAbs in immunoblotting (Figure 3) and did not
observe any reactivity with MAb3e, Mab17c, Mab19g, MAb21f or
MAb32 (11, 34). These results suggested that the epitopes
recognized by these MAbs are not present in Plp43. MAb17c is
used in affinity columns for gp43 purification [29]; however, due
to the above results it could not be used to purify rPlp43.
Therefore, we used P. pastoris culture supernatants containing
rPlp43 (and not the purified protein) in the following experiments.
We chose to work further only with rPlp43 because it is expressed
in a soluble form in culture supernatants, therefore matching the
soluble controls of native gp43 or P. pastoris gp43r3.
Reactivity of rPlp43 with PCM Patients’ Sera
We tested the rPlp43 reactivity in immunoblot with PCM
patients’ sera from Midwestern (M) and Southern (S) Brazil (Table
S1). Sera from Southwestern Brazil (50 total) were I.D.-positive
(1:2 to 1:32 or higher) against total Pb339 antigen (Table S2)
containing high amounts of gp43 as major component [20,38].
The assays were performed for either PCM diagnosis or treatment
follow up at Dr. Camargo’s laboratory. Sera from Midwestern
Brazil (51 total) were from patients confirmed for PCM with direct
microscopy, however they were I.D.-negative at Dr. Hahn’s
laboratory. These I.D. assays were carried out with similar Pb339
total antigen preparations mentioned above [20]. We then re-
evaluated these sera using I.D. with known amounts of purified
gp43, which allows for better sensitivity than culture supernatant
preparations [21]. A total of 16 out of 51 were then I.D.-positive
(pure to 1:32) against purified gp43 (Table S2). The 33 sera from
Midwestern PCM patients that were I.D.-negative (51M to 79M)
became the focus of the present work, because they apparently did
not recognize gp43.
In order to prove this hypothesis, we tested all sera listed on
Table S1 using chemiluminescence immunoblot, at a single
dilution of 1:1,000, in order to achieve the highest possible
sensitivity. As antigen, we used rPlp43 (in P. pastoris culture
supernatant); we added controls of purified native gp43 and
recombinant gp43r3 from P. pastoris [21] treated or not with
Endo H. Upon treatment with Endo H, a large percentage of gp43
is deglycosylated, but generally not 100% [11]. Therefore, we
were able to visualize reactivity with both forms, since deglyco-
sylated gp43 migrates faster at about 38 kDa. However, previously
to using Endo H-treated antigen, all sera were tested with both
gp43 and gp43r3. Figure 4A shows the types of data we obtained
and Table 1 summarizes the results. Sera from group 1 and serum
99M showed strong bands with both glycosylated and deglycosy-
lated gp43 and gp43r3, as expected from their positive I.D.
reactions. They also reacted strongly with rPlp43. Serum 100M
had similar profile, except for the lack of reactivity with rPlp43,
suggesting that the gp43 epitopes recognized by this serum are
absent in Plp43. Sera from group 2, all of them I.D.-negative from
Midwestern Brazil, did not react with any tested antigen. Four sera
(group 3 and 101M) were only reactive with glycosylated gp43 and
gp43r3, suggesting cross-reactivity with carbohydrate epitopes,
which are not specific for PCM and are also absent in Plp43.
Therefore, all ID-positive sera reacted with deglycosylated gp43,
which proved the specificity of the reaction (serum 99M was an
exception), and also with rPlp43 (with exception of 95M and
99M). That suggested that one or more gp43 peptide epitopes are
present in Plp43. On the other hand, ID-negative sera did not
recognize gp43 or rPlp43 peptide epitopes in a sensitive
immunoblot reaction. Serum 99M was an exception probably
because I.D. was not sensitive enough to detect low amounts of
antibody. Considering that the so far scare literature data point to
high concentration of P. lutzii in Midwestern Brazil [5], our results
suggest that the I.D.-negative patients were infected with P. lutzii.
We believe that this is the case based on two Midwestern gp43-
negative serum samples (51M and 52M) for which we had the
corresponding fungal isolates collected from the respective
patients. The Paracoccidioides cultures isolated from these patients
(Pb51M and Pb52M) were genotyped as P. lutzii using PCR
(Figure 4B) of aHSP70 fragment [3], thus supporting our working
hypothesis. In addition, Plp43 might be poorly expressed during
infection with P. lutzii, considering that none of the I.D.-negative
sera reacted with Plp43.
Discussion
We presently expressed Plp43, which is the closest P. lutzii
ortholog of P. brasiliensis main diagnostic antigen gp43 [8]. We
showed evidence that gp43 cannot be used in serology of PCM
caused by P. lutzii because it is not recognized by sera of patients
likely to be infected with this species. The same sera did not react
with recombinant Plp43 either, suggesting it is under expressed
during infection. Although Plp43 peptide sequence is 81%
identical with gp43, it has key differences resulting from
polymorphism in characteristic gp43 motifs. The NRT
Figure 3. Immunoblot reactivity of anti-gp43 monoclonal
antibodies with gp43 and rPlp43. Reactivity of rPlp43 was tested
with five different anti-gp43 MAbs (indicated) in immunoblot, using
gp43 as positive control. On the right, CBB-stained SDS-PAGE gel
showing the amount of antigen used in the assay. The results were the
same for HisPlp43 expressed as inclusion bodies in bacteria.
doi:10.1371/journal.pntd.0003111.g003
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N-glycosylated site is mutated to KRT in translated Plp43 and we
here experimentally confirmed that the recombinant protein is not
N-glycosylated when expressed in yeast. We also observed that the
NEP glucanase site is preserved in Plp43 and our results suggest
that it is an active glucanase, as opposed to gp43 [9]. In addition,
we tested the rPlp43 ability to bind to fibronectin in affinity-ligand
assays and at least one gp43 motif responsible for fibronectin
binding is apparently preserved in rPlp43 (data not shown).
Glycoprotein gp43 is mostly responsible for P. brasiliensis binding
to Vero cells and both laminin and fibronectin are involved in this
process [18]. Four gp43 peptides were able to inhibit binding at
different percentages, but the highest inhibition (57%) was
achieved with NLGRDAKRHL. When comparing gp43
and Plp43 sequences, only peptides that inhibited binding at
percentages lower than 30% were conserved, specifically,
SAQQKKDTLRYI (91,7% identical in Plp43) and ITEDDF-
KNIA (80% identical in Plp43).
The calculated pI for mature Plp43 is 9.5, while in gp43
isoforms the pIs vary between 6.37 and 8.35 [27]. Orthologous
mature glucanase sequences from H. capsulatum (HCAG_04584)
and B. dermatitidis (BDFG_01423) have molecular masses around
43 kDa and are 72% identical to Plp43. Their pIs are also basic,
about 8.5–8.7. On the other hand, the corresponding orthologs
from Aspergillus niger (XP_001398868.1) and A. fumigatus
(Afu1g03600), C. albicans (CAWG_01085), P. pastoris
(XP_002491361.1), and Trycophyton tonsurans (EGD99595.1),
all of them with preserved NEP active sites, are acidic (pIs 4.5 to
5.0), but with similar molecular mass (44 kDa). A phylogenetic tree
shows clear separation between the basic/neutral and the acidic
sequence clades (data not shown).
Our main goal was to assay Plp43 reactivity with PCM patients’
antibodies in comparison with gp43. This is a key type of
information in PCM diagnosis of individuals infected with P.
lutzii. Epitopes recognized by anti-gp43 MAbs 3e, 19f, 21f, 17c,
and 32 [11,29] were not detected in Plp43 when HisPlp43 and
rPlp43 were tested in immunoblot. Nevertheless, at least one
common epitope is likely to exist, considering that gp43-positive
PCM sera also reacted with rPlp43, however less intensely. On the
other hand, gp43-negative sera were also rPlp43-negative. These
sera came from patients resident in Midwestern Brazil, where P.
lutzii is apparently prevalent [5]. Indeed, two fungal samples
corresponding to gp43/Plp43-negative sera were genotyped as P.
lutzii (Figure 4B). The Brazilian Midwestern sample we presently
analyzed was composed of 51 PCM sera. If our assumption is
correct, about 69% (anti-gp43 negative sera), are from P. lutzii-
infected patients, thus corroborating the phylogenetic studies
showing prevalence of the species in that particular endemic area
[5,39]. It remains to be further tested if gp43-negative sera from
PCM patients living in other endemic areas could also be from P.
lutzii-infected patients, or if negative reactions are really due to
intense pulmonary infection/immune depression or low affinity
Figure 4. (A) Representative immunoblot reactions of PCM
patients’ sera (1:1,000) with rPlp43 and Endo H-deglycosylated
(EH-) gp43. The overall results are shown in Table 1 for sera groups 1,
2, 3, and individual sera 99M, 100M, and101M. On the right, CBB-stained
SDS-PAGE gel showing the amount of antigen used in the reactions.
Results with Endo H-deglycosylated gp43r3 were similar to (EH-)gp43
and are not shown. (B) PCR amplification of HSP70 using primers for the
P. lutzii gene as shown in an agarose gel. Partial HSP70 PCR (529 bp)
amplification shows that clinical isolates Pb51M and Pb52M are P. lutzii.
DNA extracted from Pb01 (P. lutzii) and Pb18 (P. brasiliensis) were used
as species control. Crt-, in the absence of DNA.
doi:10.1371/journal.pntd.0003111.g004
Table 1. Overall results of the I.D. and immunoblot reactivity of recombinant P. lutzii (rPlp43), native or recombinant gp43 (gp43,
gp43r3) and their Endo H-deglycosylated forms (EH-gp43, EH-gp43r3) with PCM patients’ sera from Brazilian Southeastern (S) and
Midwestern (M) regions (Table S1).
Group* or serum ID# rPlp43 Gp43 or gp43r3 EH-gp43 or EH-gp43r3
1 + + + +
2 2 2 2 2
3 2 2 + 2
99M 2 + + +
100M + 2 + +
101M + 2 + 2
*Sera groups: 1, 1S–50S and 82M–95M; 2, 51M–81M; 3, 96M–98M.
#ID titers with purified gp43 or Pb339 culture supernantant are specified in Table S2.
doi:10.1371/journal.pntd.0003111.t001
Antigenic Characterization of Recombinant Plp43
PLOS Neglected Tropical Diseases | www.plosntds.org 7 August 2014 | Volume 8 | Issue 8 | e3111
antibodies recognizing carbohydrate epitopes [24,26]. It is worth
noticing that reactions against gp43 carbohydrate epitopes cannot
be considered specific to PCM because these epitopes are
promiscuous among fungi [8].
We believe that Plp43 is expressed at low amounts by P. lutzii
both in vivo and in vitro, considering that anti-HisPlp43 rabbit
serum presently produced did not react with any Pb01 culture
supernatant, intracellular or cell wall extract component in
immunoblot (data not shown). Regulation of gp43 expression is
still poorly understood and transcription levels vary with the isolate
[40,41]. We have studied the 59 non-translated region of the
PbGP43 gene and observed that it differs from that of the
PlP43 gene, probably leading to distinct regulation and lower
transcription.
In conclusion, our data suggested that although there is at least
one common epitope between gp43 and Plp43, gp43 cannot be
used in diagnosis of PCM patients infected with P. lutzii because
Plp43 is apparently poorly expressed during infection.
Supporting Information
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